{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:03:33Z","timestamp":1768889013928,"version":"3.49.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,13]]},"DOI":"10.1093\/jbcr\/irx023","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T14:33:29Z","timestamp":1522420409000},"page":"585-592","source":"Crossref","is-referenced-by-count":16,"title":["Variability in Management of Patients With SJS\/TEN: A Survey of Burn Unit Directors"],"prefix":"10.1093","volume":"39","author":[{"given":"Emily B","family":"Richard","sequence":"first","affiliation":[{"name":"Internal Medicine Residency Program, Louisiana State University Health Sciences Center, New Orleans"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Hamer","sequence":"additional","affiliation":[{"name":"Division of Academic Affairs, Our Lady of the Lake Regional Medical Center, Baton Rouge LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandi W","family":"Musso","sequence":"additional","affiliation":[{"name":"Division of Academic Affairs, Our Lady of the Lake Regional Medical Center, Baton Rouge LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracee","family":"Short","sequence":"additional","affiliation":[{"name":"Burn Unit, Baton Rouge General Medical Center, LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Hollis R","family":"O\u2019Neal","sequence":"additional","affiliation":[{"name":"Internal Medicine Residency Program, Louisiana State University Health Sciences Center, New Orleans"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"issue":"8","key":"key\n\t\t\t\t20180613065839_CIT0001","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180613065839_CIT0002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"24","key":"key\n\t\t\t\t20180613065839_CIT0003","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"issue":"4","key":"key\n\t\t\t\t20180613065839_CIT0004","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20180613065839_CIT0005","doi-asserted-by":"crossref","first-page":"173 e171","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"key\n\t\t\t\t20180613065839_CIT0006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2042098611404094","article-title":"Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality","volume":"2","author":"Roujeau","year":"2011","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"key\n\t\t\t\t20180613065839_CIT0007","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"3","key":"key\n\t\t\t\t20180613065839_CIT0008","first-page":"273","article-title":"Burn center care for patients with toxic epidermal necrolysis","volume":"180","author":"Kelemen","year":"1995","journal-title":"J Am Coll Surg"},{"issue":"5","key":"key\n\t\t\t\t20180613065839_CIT0009","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1542\/peds.108.5.1162","article-title":"Treatment of extensive toxic epidermal necrolysis in children","volume":"108","author":"Spies","year":"2001","journal-title":"Pediatrics"},{"issue":"5","key":"key\n\t\t\t\t20180613065839_CIT0010","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"6","key":"key\n\t\t\t\t20180613065839_CIT0011","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40257-015-0158-0","article-title":"Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update","volume":"16","author":"Dodiuk-Gad","year":"2015","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"key\n\t\t\t\t20180613065839_CIT0012","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.burns.2014.02.006","article-title":"A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres","volume":"40","author":"Mahar","year":"2014","journal-title":"Burns"},{"issue":"2","key":"key\n\t\t\t\t20180613065839_CIT0013","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004630-200203000-00004","article-title":"A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century","volume":"23","author":"Palmieri","year":"2002","journal-title":"J Burn Care Rehabil"},{"issue":"4","key":"key\n\t\t\t\t20180613065839_CIT0014","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00006534-199809020-00014","article-title":"Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center","volume":"102","author":"McGee","year":"1998","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"key\n\t\t\t\t20180613065839_CIT0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/BCR.0b013e3182a2ad17","article-title":"Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome","volume":"34","author":"Davis","year":"2013","journal-title":"J Burn Care Res"},{"issue":"10","key":"key\n\t\t\t\t20180613065839_CIT0016","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1365-4632.2007.03277.x","article-title":"Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"46","author":"Fromowitz","year":"2007","journal-title":"Int J Dermatol"},{"issue":"5","key":"key\n\t\t\t\t20180613065839_CIT0017","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/BCR.0b013e3181848bb1","article-title":"Toxic epidermal necrolysis clinical guidelines","volume":"29","author":"Endorf","year":"2008","journal-title":"J Burn Care Res"},{"issue":"6","key":"key\n\t\t\t\t20180613065839_CIT0018","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer","year":"2016","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t20180613065839_CIT0019","author":"Institute NIoHNHGR","year":"2015"},{"key":"key\n\t\t\t\t20180613065839_CIT0020","author":"Association AB","year":"2015"},{"issue":"3","key":"key\n\t\t\t\t20180613065839_CIT0021","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004630-200021030-00004","article-title":"A 10-year experience with toxic epidermal necrolysis","volume":"21","author":"Schulz","year":"2000","journal-title":"J Burn Care Rehabil"},{"issue":"3","key":"key\n\t\t\t\t20180613065839_CIT0022","first-page":"413","article-title":"Clinical considerations for epidermal necrolysis","volume":"14","author":"Ellender","year":"2014","journal-title":"Ochsner J"},{"issue":"1","key":"key\n\t\t\t\t20180613065839_CIT0023","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jbcr\/28.1.134","article-title":"Guidelines for the operation of burn centers","volume":"28","author":"American Burn Association\/American College of S","year":"2007","journal-title":"J Burn Care Res"},{"issue":"2","key":"key\n\t\t\t\t20180613065839_CIT0024","doi-asserted-by":"crossref","first-page":"187 e181","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"key\n\t\t\t\t20180613065839_CIT0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MD.0b013e3181ca4290","article-title":"Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures","volume":"89","author":"de Prost","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"key\n\t\t\t\t20180613065839_CIT0026","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1128\/CMR.19.2.403-434.2006","article-title":"Burn wound infections","volume":"19","author":"Church","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"key\n\t\t\t\t20180613065839_CIT0027","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.burns.2009.06.198","article-title":"Infection control in the burn unit","volume":"37","author":"Rafla","year":"2011","journal-title":"Burns"},{"issue":"8","key":"key\n\t\t\t\t20180613065839_CIT0028","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bjps.2014.04.003","article-title":"Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm","volume":"67","author":"Abela","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"4","key":"key\n\t\t\t\t20180613065839_CIT0029","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ajd.12254","article-title":"Role of nanocrystalline silver dressings in the management of toxic epidermal necrolysis (TEN) and TEN\/Stevens-Johnson syndrome overlap","volume":"56","author":"Smith","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"4","key":"key\n\t\t\t\t20180613065839_CIT0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.burns.2015.12.001","article-title":"Burn unit care of Stevens Johnson syndrome\/toxic epidermal necrolysis: A survey","volume":"42","author":"Le","year":"2016","journal-title":"Burns"},{"issue":"1","key":"key\n\t\t\t\t20180613065839_CIT0031","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","article-title":"Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression","volume":"139","author":"Bachot","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"key\n\t\t\t\t20180613065839_CIT0032","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20180613065839_CIT0033","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1529-8019.2011.01396.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options","volume":"24","author":"Worswick","year":"2011","journal-title":"Dermatol Ther"},{"issue":"5","key":"key\n\t\t\t\t20180613065839_CIT0034","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaad.2014.07.016","article-title":"Retrospective review of Stevens-Johnson syndrome\/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine","volume":"71","author":"Kirchhof","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"key\n\t\t\t\t20180613065839_CIT0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaad.2014.04.044","article-title":"Etanercept therapy for toxic epidermal necrolysis","volume":"71","author":"Paradisi","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"key\n\t\t\t\t20180613065839_CIT0036","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.burns.2015.03.012","article-title":"Complications of Stevens-Johnson syndrome beyond the eye and skin","volume":"42","author":"Saeed","year":"2016","journal-title":"Burns"},{"issue":"2","key":"key\n\t\t\t\t20180613065839_CIT0037","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","article-title":"Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease","volume":"14","author":"Kohanim","year":"2016","journal-title":"Ocul Surf"},{"issue":"9","key":"key\n\t\t\t\t20180613065839_CIT0038","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/epi.12325","article-title":"Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand","volume":"54","author":"Rattanavipapong","year":"2013","journal-title":"Epilepsia"},{"issue":"6982","key":"key\n\t\t\t\t20180613065839_CIT0039","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"issue":"1","key":"key\n\t\t\t\t20180613065839_CIT0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/tpj.2011.41","article-title":"A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"13","author":"Tohkin","year":"2013","journal-title":"Pharmacogenomics J"},{"issue":"8","key":"key\n\t\t\t\t20180613065839_CIT0041","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/FPC.0000000000000147","article-title":"A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout","volume":"25","author":"Roberts","year":"2015","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"key\n\t\t\t\t20180613065839_CIT0042","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00228-013-1622-5","article-title":"HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome\/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique","volume":"70","author":"Borgiani","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"key\n\t\t\t\t20180613065839_CIT0043","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jaci.2014.12.1916","article-title":"IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome\/toxic epidermal necrolysis with severe mucosal involvement","volume":"135","author":"Ueta","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"key\n\t\t\t\t20180613065839_CIT0044","doi-asserted-by":"crossref","first-page":"15023","DOI":"10.1038\/hgv.2015.23","article-title":"HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens-Johnson syndrome with severe ocular complications","volume":"2","author":"Ueta","year":"2015","journal-title":"Hum Genome Var"}],"container-title":["Journal of Burn Care & Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jbcr\/article-pdf\/39\/4\/585\/25040333\/irx023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T15:46:40Z","timestamp":1570981600000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbcr\/article\/39\/4\/585\/4846884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,2,9]]},"published-print":{"date-parts":[[2018,6,13]]}},"URL":"https:\/\/doi.org\/10.1093\/jbcr\/irx023","relation":{},"ISSN":["1559-047X","1559-0488"],"issn-type":[{"value":"1559-047X","type":"print"},{"value":"1559-0488","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,2,9]]}}}